
Gilead has entered into an agreement with Canadian monoclonal antibody discovery firm AbCellera. The two firms will take part in …

Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …

Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

